Palmoplantar Pustulosis Market: Why Did a Drug That Worked for Generalized Pustular Psoriasis Fail for Its Close Cousin?
The palmoplantar pustulosis (PPP) treatment market — therapies for a rare, chronic inflammatory skin condition causing recurrent sterile pustules on the palms and soles, closely related to but clinically distinct from psoriasis — is expanding steadily as biologic therapy adoption grows, even as the field navigates a genuinely instructive series of clinical trial setbacks, with the...
0 Commentaires 0 Parts 30 Vue 0 Aperçu